Answers are grounded in this paper and cite their sources.
Demonstrates the impact of HK2 knockdown on inflammatory and angiogenesis pathways in glioblastoma, suggesting new therapeutic strategies.
Introduction Deregulation of cellular metabolism is a hallmark of cancer, in which tumour cells upregulate glycolysis and preferentially ferment glucose to lactate in the ‘Warburg effect’. Tumour-specific upregulation of hexokinase 2 ( HK2 ), which catalyses the first rate-limiting step of glycolysis, is a key driver of this phenotype and represents a promising therapeutic target in glioblastoma. Here, we sought to identify HK2-associated tumour processes that could serve as therapeutic co-targets by profiling the transcriptomic consequences of HK2 knockdown (HK2KD) in model established glioblastoma cell lines and patient-derived short-term cell cultures. Methods Glioblastoma cell lines and patient-derived short-term cell cultures were subjected to HK2KD using HK2 -targeted siRNA. Glycolytic activity was assessed using the Seahorse Glycolytic Stress Test, and transcriptomic changes were analysed by RNA sequencing. Results HK2KD was associated with reduced glycolytic activity in high- HK2 -expressing models as well as extensive transcriptional remodelling. Integrative analysis using RNA sequencing, gene ontology and pathway enrichment, protein-protein interaction networks, and transcriptome-based perturbation matching indicated coordinated modulation of inflammatory, immune-associated and angiogenesis-linked gene programmes, including cytokine, chemokine and pro-angiogenic signalling axes. Notably, inflammatory pathway responses diverged markedly between independent glioblastoma models, representing a central finding of this study and highlighting context-dependent immunometabolic transcriptional changes following HK2KD. Discussion These findings suggest that HK2KD is associated with transcriptional changes extending beyond glycolytic pathways, linking metabolic activity to immunological and angiogenic transcriptional networks in a model-dependent manner. Although functional effects on the tumour microenvironment were not directly assessed, this study provides a transcriptomic framework for understanding how HK2 targeting may be associated with changes in tumour-associated signalling pathways, with potential implications for stratified metabolic and combination therapeutic strategies in glioblastoma.
No takes yet. Share an insight, caveat, or question.
Edwards et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: